サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1584113

E型肝炎診断検査市場：製品タイプ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024-2032年予測

Hepatitis E Diagnostic Tests Market, By Product Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
E型肝炎診断検査市場：製品タイプ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年10月26日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

E型肝炎診断検査市場規模は2023年に5,352万米ドルとなり、2024年から2032年にかけてCAGR 4.80%で拡大

E型肝炎診断検査市場-市場力学

早期診断とタイムリーな治療ニーズの高まりが市場需要を促進

E型肝炎診断検査の世界市場は、近年著しい技術進歩に見舞われており、診断ソリューションの精度、効率、アクセシビリティが向上しています。例えば、DiaSorin社は2021年6月、E型肝炎診断のための完全自動化ハイスループットCLIAソリューションを発売し、CEマークを承認する国で利用できるようになった。この新しいソリューションは、E型肝炎診断における重要な改善点であり、ヘルスケアプロバイダーがハイスループット検査を効率的に実施できるようにします。この機能は、E型肝炎の有病率が高い地域では特に重要であり、感染者の迅速な特定は効果的な疾病管理と予防に不可欠です。このような先進的な診断プラットフォームのイントロダクションは、正確で効率的な検査ソリューションに対する需要の高まりに応えるものです。ヘルスケア提供者、リスクのある人々、一般市民の意識を高める努力も、市場成長を促進する上で極めて重要です。妊婦の死亡率の上昇など、E型肝炎のリスクと結果に対する意識の高まりが、正確な診断検査に対する需要を後押ししています。WHOの2023年必須診断薬リストにE型肝炎検査が含まれたことは、E型肝炎の早期発見と管理の重要性が世界的に認識されていることを浮き彫りにしています。各国政府やヘルスケアシステムは、サーベイランスの改善とアウトブレイク管理の必要性をますます認識するようになっており、HEV診断キットの調達拡大につながっています。さらに、患者や臨床医は早期診断と適時治療を可能にするE型肝炎検査へのアクセス向上を求めており、市場の成長をさらに後押ししています。例えば、インド政府の包括的な国家ウイルス性肝炎対策プログラムは、予防、診断、治療に焦点を当てた多面的なアプローチを通じて、E型肝炎を含むあらゆる形態のウイルス性肝炎の負担に対処することを目的としています。このプログラムでは、ウイルス性肝炎を効果的に管理するヘルスケアシステムの能力を強化するため、多額の政府資金と地方分権的な実施戦略が用いられています。特に新興市場におけるヘルスケア支出の増加も、市場の成長を支えています。早期発見と効果的な疾患管理が重視されるようになり、診断検査に対する需要が高まっています。E型肝炎に対する認識が高まるにつれ、ウイルスの蔓延を緩和するために、個人の衛生、安全な水源、適切な衛生管理、食品の安全性などの予防対策を実施することに重点が置かれるようになっています。

E型肝炎診断検査市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約4.80%のCAGRで毎年成長すると予測されています。

製品タイプ別では、ELISA HEV IgM検査が2023年に最大の市場シェアを示すと予測されます。

最終用途別では、2023年には病院が主要タイプでした。

地域別では、北米が2023年に主要な収益源となった。

E型肝炎診断検査市場-セグメンテーション分析：

世界のE型肝炎診断検査市場は、製品タイプ、最終用途、地域に基づいてセグメント化されます。

市場は製品タイプに基づいて4つのカテゴリーに分けられる：すなわち、ELISA HEV IgM検査、ELISA HEV IgG検査、迅速診断検査、ポリメラーゼ連鎖反応（PCR）です。タイプ別では、ELISA HEV IgM検査セグメントが2023年に最大の収益シェアでE型肝炎診断検査市場をリードしました。この優位性は主に、急性または最近（6カ月未満）の感染を特定するために、E型肝炎ウイルス（HEV）に対するIgMクラスの抗体を検出するという重要な役割によるものです。IgM抗体の存在は、急性E型肝炎の診断に不可欠であり、通常は追跡RNA検査によって確認されます。ELISAベースのIgM検査は感度と特異度が高いため、HEVの初回スクリーニングに適しています。例えば、Dia.Proは、ヒト血清または血漿中のHEVに対するIgM抗体を検出するために特別に設計されたHEV-IgM ELISA検査キットを提供しています。特に衛生環境が不十分な発展途上地域でのE型肝炎感染の増加により、ELISA HEV IgM検査のような効果的な診断ツールの需要が大幅に高まっています。

市場は最終用途に基づいて4つのカテゴリーに分けられる：病院、血液バンク、診断研究所、その他の最終用途です。最終用途別では、病院セグメントが2023年に最大の収益シェアを獲得して市場をリードしています。この動向は主に、世界的に病院で診断・治療されるE型肝炎患者の有病率が高いことに起因しています。病院には、高度な診断設備、多様な医療専門家、E型肝炎症例を効率的に診断・管理するために必要なインフラが備わっています。さらに、病院はより複雑な症例の紹介センターとして機能することが多く、世界市場における大きな収益シェアをさらに高めています。

E型肝炎診断検査市場-地理的洞察

同市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカと、地理的に分散した顧客基盤に対応しています。これらの地域内の参入企業が市場のサブセグメントを形成しています。北米のE型肝炎診断検査市場は、2023年に大きなシェアを占めました。同地域は、病院、診断研究所、研究センターからなるヘルスケアインフラが確立されており、診断検査の採用に適した環境を提供することで市場の成長を支えています。さらに、感染症診断の研究開発に対する政府の取り組みや資金援助は、新たな診断ソリューションの開発や採用を促進し、市場の成長に寄与しています。例えば、2024年4月、ミネソタ大学Hormel研究所のSusan Hafenstein博士は、Nationwide Children's Hospitalから85,000ドルのNIH助成金を受け、E型肝炎の新たな治療法と予防戦略を生み出すことを目的としたHEVの低温電子顕微鏡調査を支援しました。

E型肝炎診断検査市場-競合情勢：

E型肝炎診断検査市場の各社は、競争力を強化し市場リーチを拡大するために様々な戦略を採用しています。研究開発に重点を置くことは極めて重要であり、検査の感度と特異度の向上、迅速かつポイントオブケアな検査ソリューションの開発に注力しています。ヘルスケア機関や検査施設との戦略的協力関係は、臨床検証を促進し、新しい検査の普及を促進します。マーケティング戦略は、合併症予防における早期発見の重要性を強調し、特にヘルスケアプロバイダーや公衆衛生機関をターゲットとしています。さらに、各社はE型肝炎のリスクや検査可能性についての認識を高めるための教育的な取り組みも頻繁に行っており、診断薬が肝臓の健康管理に不可欠なものとなっています。

目次

第1章 E型肝炎診断検査市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 E型肝炎診断検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 E型肝炎診断検査業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 E型肝炎診断検査市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 E型肝炎診断検査市場情勢

  • E型肝炎診断検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 E型肝炎診断検査市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ELISA HEV IgM検査
    • ELISA HEV IgG検査
    • 迅速診断テスト
    • ポリメラーゼ連鎖反応（PCR）

第8章 E型肝炎診断検査市場- 最終用途別

  • 概要
    • 最終用途別セグメントシェア分析
    • 病院
    • 診断研究所
    • 血液バンク
    • その他の最終用途

第9章 E型肝炎診断検査市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析-E型肝炎診断検査業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Altona Diagnostics
    • Dia.Pro Diagnostic Bioprobes srl
    • ELITechGroup
    • F. Hoffmann-La Roche Ltd
    • Fortress Diagnostics
    • Mikrogen GmbH
    • MP Biomedicals LLP
    • PerkinElmer, Inc
    • Primerdesign Ltd
    • Wantai BioPharm
    • Others

第11章 アナリストの全方位展望

目次
Product Code: ANV4064

REPORT HIGHLIGHT

Hepatitis E Diagnostic Tests Market size was valued at USD 53.52 Million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

Hepatitis E diagnostic tests are medical assays designed to detect the presence of the Hepatitis E virus (HEV), which causes liver inflammation. These tests typically utilize serological methods to identify antibodies (anti-HEV IgM and IgG) or molecular techniques such as PCR polymerase chain reaction (PCR) to detect viral RNA. Early and accurate diagnosis is crucial for managing hepatitis E, especially in pregnant women and individuals with compromised liver function, as the infection can result in severe complications. Hepatitis E diagnostics play a vital role in public health monitoring and controlling outbreaks, particularly in regions where the virus is endemic.

Hepatitis E Diagnostic Tests Market- Market Dynamics

Increasing need of early diagnosis and timely treatment to propel market demand

The global market for hepatitis E diagnostics has experienced significant technological advancements in recent years, enhancing the accuracy, efficiency, and accessibility of diagnostic solutions. For instance, in June 2021, DiaSorin launched fully automated high-throughput CLIA solution for the hepatitis E diagnosis, available in countries that accept the CE mark. This new offering represents a important improvement in hepatitis E diagnostics, allowing healthcare providers to conduct high-throughput testing efficiently. This capability is particularly important in regions with high hepatitis E prevalence, where rapid identification of infected individuals is essential for effective disease management and prevention. The introduction of such advanced diagnostic platforms meets the growing demand for accurate and efficient testing solutions. Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also crucial in driving market growth. Increased awareness of the risks and consequences of hepatitis E, including higher mortality rates in pregnant women, is fueling demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List highlights the global recognition of the importance of early detection and management of the disease. Governments and healthcare systems are increasingly acknowledging the need for improved surveillance and outbreak management, leading to greater procurement of HEV diagnostic kits. Additionally, patients and clinicians are seeking better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For example, the Government of India's comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. This program involves significant government funding and a decentralized implementation strategy to enhance the healthcare system's capacity to manage viral hepatitis effectively. Increasing healthcare expenditure, particularly in emerging markets, is also supporting market growth. The emphasis on early detection and effective disease management is driving demand for diagnostic tests. As awareness about hepatitis E grows, there is a heightened focus on implementing preventive measures, including personal hygiene, safe water sources, proper sanitation, and food safety, to mitigate the virus's spread.

Hepatitis E Diagnostic Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on Product Type segmentation, ELISA HEV IgM test was predicted to show maximum market share in the year 2023

Based on End-use segmentation, the hospital was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hepatitis E Diagnostic Tests Market- Segmentation Analysis:

The Global Hepatitis E Diagnostic Tests Market is segmented on the basis of Product Type, End-use, and Region.

The market is divided into four categories based on product type: ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test and Polymerase Chain Reaction (PCR). Based on type, the ELISA HEV IgM test segment led the hepatitis E diagnostic tests market with the largest revenue share in 2023. This dominance is primarily due to the critical role of detecting IgM-class antibodies to the hepatitis E virus (HEV) for identifying acute or recent infections (less than six months). The presence of IgM antibodies is essential for diagnosing acute hepatitis E, typically confirmed by follow-up RNA testing. The high sensitivity and specificity of ELISA-based IgM tests make them the preferred option for initial HEV screening. For example, Dia.Pro offers the HEV-IgM ELISA test kit, specifically designed to detect IgM antibodies against HEV in human serum or plasma. The increasing incidence of hepatitis E infections, especially in developing regions with inadequate sanitation and hygiene practices, has significantly boosted the demand for effective diagnostic tools like the ELISA HEV IgM test.

The market is divided into four categories based on End use: Hospital, Blood Banks, Diagnostics Laboratories, and Other End User. In terms of end use, the hospital segment was leading the market with the largest revenue share in 2023. This trend is primarily driven by the high prevalence of hepatitis E cases being diagnosed and treated in hospitals globally. Hospitals are equipped with advanced diagnostic facilities, a diverse range of healthcare professionals, and the necessary infrastructure to efficiently diagnose and manage hepatitis E cases. Moreover, hospitals often act as referral centers for more complex cases, further enhancing their significant revenue share in the global market.

Hepatitis E Diagnostic Tests Market- Geographical Insights

This market caters to a geographically scattered customer base, spanning North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Participating nations within these regions create sub-segments within the market. The hepatitis E diagnostic tests market in North America accounted for a significant share in 2023. The region's well-established healthcare infrastructure, comprising hospitals, diagnostic laboratories, and research centers, supports market growth by providing a conducive environment for the adoption of diagnostic tests. Additionally, government initiatives and funding for research and development in infectious disease diagnostics contribute to market growth by facilitating the development and adoption of new diagnostic solutions. For instance, in April 2024, Dr. Susan Hafenstein of The Hormel Institute at the University of Minnesota received an $85,000 NIH-funded grant from Nationwide Children's Hospital to support her cryoEM research into HEV, with the goal of creating new treatments and prevention strategies for hepatitis E.

Hepatitis E Diagnostic Tests Market- Competitive Landscape:

Companies in the hepatitis E diagnostic tests market employ various strategies to enhance competitiveness and expand their market reach. Emphasizing research and development is crucial, with efforts focused on improving test sensitivity and specificity, as well as creating rapid and point-of-care testing solutions. Strategic collaborations with healthcare institutions and laboratories help facilitate clinical validation and promote the widespread adoption of new tests. Marketing strategies highlight the importance of early detection in preventing complications, specifically targeting healthcare providers and public health agencies. Additionally, companies frequently engage in educational initiatives to raise awareness about the risks of hepatitis E and the availability of testing, ensuring that diagnostics become an integral part of liver health management.

Recent Developments:

In November 2023, Roche introduced two automated immunoassays, the Elecsys Anti-HEV IgG and the Elecsys Anti-HEV IgM, designed to detect hepatitis E virus infections. These tests are available in countries that recognize the CE mark, including members of the European Union.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Altona Diagnostics
  • Dia.Pro Diagnostic Bioprobes srl
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • Mikrogen GmbH
  • MP Biomedicals LLP
  • PerkinElmer, Inc
  • Primerdesign Ltd
  • Wantai BioPharm
  • Others

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • Polymerase Chain Reaction (PCR)

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Diagnostics Laboratories
  • Blood Banks
  • Other End User

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hepatitis E Diagnostic Tests Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hepatitis E Diagnostic Tests Market Snippet by Product Type
    • 2.1.2. Hepatitis E Diagnostic Tests Market Snippet by End Use
    • 2.1.3. Hepatitis E Diagnostic Tests Market Snippet by Country
    • 2.1.4. Hepatitis E Diagnostic Tests Market Snippet by Region
  • 2.2. Competitive Insights

3. Hepatitis E Diagnostic Tests Key Market Trends

  • 3.1. Hepatitis E Diagnostic Tests Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hepatitis E Diagnostic Tests Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hepatitis E Diagnostic Tests Market Opportunities
  • 3.4. Hepatitis E Diagnostic Tests Market Future Trends

4. Hepatitis E Diagnostic Tests Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hepatitis E Diagnostic Tests Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hepatitis E Diagnostic Tests Market Landscape

  • 6.1. Hepatitis E Diagnostic Tests Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hepatitis E Diagnostic Tests Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. ELISA HEV IgM Test
    • 7.1.3. ELISA HEV IgG Test
    • 7.1.4. Rapid Diagnostics Test
    • 7.1.5. Polymerase Chain Reaction (PCR)

8. Hepatitis E Diagnostic Tests Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 8.1.2. Hospital
    • 8.1.3. Diagnostics Laboratories
    • 8.1.4. Blood Banks
    • 8.1.5. Other End User

9. Hepatitis E Diagnostic Tests Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hepatitis E Diagnostic Tests Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hepatitis E Diagnostic Tests Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hepatitis E Diagnostic Tests Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hepatitis E Diagnostic Tests Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hepatitis E Diagnostic Tests Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hepatitis E Diagnostic Tests Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Altona Diagnostics
    • 10.2.2. Dia.Pro Diagnostic Bioprobes srl
    • 10.2.3. ELITechGroup
    • 10.2.4. F. Hoffmann-La Roche Ltd
    • 10.2.5. Fortress Diagnostics
    • 10.2.6. Mikrogen GmbH
    • 10.2.7. MP Biomedicals LLP
    • 10.2.8. PerkinElmer, Inc
    • 10.2.9. Primerdesign Ltd
    • 10.2.10. Wantai BioPharm
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us